Federal law criminalizes forced abortion, expands civil remedies for victims
S. 2955 — Forced Abortion Prevention and Accountability Act · Filed by Jim Banks (R-IN) · 23 cosponsors · Introduced Sep 30, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates federal criminal and civil penalties for administering abortion-inducing drugs to a woman without her informed consent, if the drug has been shipped in interstate commerce. It establishes up to 25 years imprisonment for the offense, allows victims to sue for damages (including treble damages and punitive damages), and requires courts to award attorney's fees to prevailing plaintiffs. The bill also broadens the definition of 'conspiracy' to include selling or mailing abortion drugs without verifying the recipient is a pregnant woman seeking an abortion.
Why we flagged it
The bill's operative mechanism is straightforward: it criminalizes non-consensual administration of abortion drugs and creates civil remedies for victims. This is a protective statute, not a regulatory carve-out or subsidy. The title accurately describes the function.
What the text implies
- The definition of 'conspiracy' in subsection (e)(3) extends liability to anyone 'selling, sending by shipping or mailing, or giving an abortion-inducing drug without taking reasonable measures to ensure the individual requesting the drug is a pregnant woman wishing to obtain an abortion.' This may create liability for mail carriers, pharmacists, or online retailers who cannot verify the recipient'
- The bill's interstate commerce hook (requiring the drug to have been 'shipped or transported in interstate commerce') means virtually all mifepristone and misoprostol cases will fall under federal jurisdiction, potentially federalizing what might otherwise be state criminal law and creating dual-prosecution risk.
The full analysis lists 3 implications of this text.
Who stands to gain
plaintiff's attorneys (contingency fee opportunity); medical malpractice insurers (increased claims exposure)